vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Elastic N.V. (ESTC). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $423.5M, roughly 1.2× Elastic N.V.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -12.1%, a 2.0% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 15.9%). Elastic N.V. produced more free cash flow last quarter ($26.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 13.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Elastic is a Dutch-American software company that provides a platform for enterprise search, observability, and cybersecurity. Its product enables users to search and analyze large-scale data, monitor system performance, and detect anomalies. Originally known as Elasticsearch, the company was founded in 2012 in Amsterdam, Netherlands, and has maintained its operational headquarters in both the Netherlands and San Francisco, California, US. Elastic is publicly traded on the New York Stock Exch...

CLOV vs ESTC — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.2× larger
CLOV
$487.7M
$423.5M
ESTC
Growing faster (revenue YoY)
CLOV
CLOV
+28.8% gap
CLOV
44.7%
15.9%
ESTC
Higher net margin
CLOV
CLOV
2.0% more per $
CLOV
-10.1%
-12.1%
ESTC
More free cash flow
ESTC
ESTC
$95.0M more FCF
ESTC
$26.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
13.6%
ESTC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CLOV
CLOV
ESTC
ESTC
Revenue
$487.7M
$423.5M
Net Profit
$-49.3M
$-51.3M
Gross Margin
75.9%
Operating Margin
-10.1%
-1.9%
Net Margin
-10.1%
-12.1%
Revenue YoY
44.7%
15.9%
Net Profit YoY
-123.2%
-101.5%
EPS (diluted)
$-0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ESTC
ESTC
Q4 25
$487.7M
$423.5M
Q3 25
$496.6M
$415.3M
Q2 25
$477.6M
$388.4M
Q1 25
$462.3M
$382.1M
Q4 24
$337.0M
$365.4M
Q3 24
$331.0M
$347.4M
Q2 24
$356.3M
$335.0M
Q1 24
$346.9M
$328.0M
Net Profit
CLOV
CLOV
ESTC
ESTC
Q4 25
$-49.3M
$-51.3M
Q3 25
$-24.4M
$-24.6M
Q2 25
$-10.6M
$-16.4M
Q1 25
$-1.3M
$-17.1M
Q4 24
$-22.1M
$-25.4M
Q3 24
$-9.2M
$-49.2M
Q2 24
$7.4M
$-41.1M
Q1 24
$-19.2M
$176.1M
Gross Margin
CLOV
CLOV
ESTC
ESTC
Q4 25
75.9%
Q3 25
76.7%
Q2 25
74.8%
Q1 25
74.6%
Q4 24
74.5%
Q3 24
24.5%
73.6%
Q2 24
30.3%
73.8%
Q1 24
23.6%
74.2%
Operating Margin
CLOV
CLOV
ESTC
ESTC
Q4 25
-10.1%
-1.9%
Q3 25
-4.9%
-2.3%
Q2 25
-2.2%
-3.1%
Q1 25
-0.3%
-1.2%
Q4 24
-6.4%
-1.2%
Q3 24
-2.7%
-9.7%
Q2 24
2.0%
-13.6%
Q1 24
-6.5%
-8.1%
Net Margin
CLOV
CLOV
ESTC
ESTC
Q4 25
-10.1%
-12.1%
Q3 25
-4.9%
-5.9%
Q2 25
-2.2%
-4.2%
Q1 25
-0.3%
-4.5%
Q4 24
-6.6%
-7.0%
Q3 24
-2.8%
-14.2%
Q2 24
2.1%
-12.3%
Q1 24
-5.5%
53.7%
EPS (diluted)
CLOV
CLOV
ESTC
ESTC
Q4 25
$-0.48
Q3 25
$-0.23
Q2 25
$-0.15
Q1 25
$-0.16
Q4 24
$-0.25
Q3 24
$-0.48
Q2 24
$-0.35
Q1 24
$1.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ESTC
ESTC
Cash + ST InvestmentsLiquidity on hand
$78.3M
$1.4B
Total DebtLower is stronger
$570.3M
Stockholders' EquityBook value
$308.7M
$891.1M
Total Assets
$541.0M
$2.5B
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ESTC
ESTC
Q4 25
$78.3M
$1.4B
Q3 25
$1.5B
Q2 25
$1.4B
Q1 25
$584.0M
Q4 24
$194.5M
$658.5M
Q3 24
$288.0M
$594.9M
Q2 24
$254.8M
$1.1B
Q1 24
$208.3M
$526.9M
Total Debt
CLOV
CLOV
ESTC
ESTC
Q4 25
$570.3M
Q3 25
$570.0M
Q2 25
$569.7M
Q1 25
$569.4M
Q4 24
$569.2M
Q3 24
$568.9M
Q2 24
$568.6M
Q1 24
$568.3M
Stockholders' Equity
CLOV
CLOV
ESTC
ESTC
Q4 25
$308.7M
$891.1M
Q3 25
$340.9M
$971.4M
Q2 25
$344.2M
$927.2M
Q1 25
$336.1M
$859.1M
Q4 24
$341.1M
$811.5M
Q3 24
$342.2M
$759.4M
Q2 24
$324.9M
$738.2M
Q1 24
$292.5M
$707.8M
Total Assets
CLOV
CLOV
ESTC
ESTC
Q4 25
$541.0M
$2.5B
Q3 25
$559.7M
$2.5B
Q2 25
$575.0M
$2.6B
Q1 25
$583.7M
$2.3B
Q4 24
$580.7M
$2.2B
Q3 24
$653.0M
$2.2B
Q2 24
$674.2M
$2.2B
Q1 24
$671.8M
$2.1B
Debt / Equity
CLOV
CLOV
ESTC
ESTC
Q4 25
0.64×
Q3 25
0.59×
Q2 25
0.61×
Q1 25
0.66×
Q4 24
0.70×
Q3 24
0.75×
Q2 24
0.77×
Q1 24
0.80×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ESTC
ESTC
Operating Cash FlowLast quarter
$-66.9M
$26.6M
Free Cash FlowOCF − Capex
$-69.0M
$26.0M
FCF MarginFCF / Revenue
-14.1%
6.1%
Capex IntensityCapex / Revenue
0.4%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$302.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ESTC
ESTC
Q4 25
$-66.9M
$26.6M
Q3 25
$12.1M
$104.8M
Q2 25
$5.4M
$87.0M
Q1 25
$-16.3M
$88.1M
Q4 24
$34.8M
$38.4M
Q3 24
$50.0M
$52.8M
Q2 24
$44.8M
$60.9M
Q1 24
$25.9M
$52.4M
Free Cash Flow
CLOV
CLOV
ESTC
ESTC
Q4 25
$-69.0M
$26.0M
Q3 25
$11.4M
$104.2M
Q2 25
$4.8M
$84.9M
Q1 25
$-16.5M
$87.3M
Q4 24
$33.3M
$37.7M
Q3 24
$49.6M
$52.0M
Q2 24
$44.4M
$60.1M
Q1 24
$25.5M
$51.3M
FCF Margin
CLOV
CLOV
ESTC
ESTC
Q4 25
-14.1%
6.1%
Q3 25
2.3%
25.1%
Q2 25
1.0%
21.8%
Q1 25
-3.6%
22.8%
Q4 24
9.9%
10.3%
Q3 24
15.0%
15.0%
Q2 24
12.5%
17.9%
Q1 24
7.3%
15.6%
Capex Intensity
CLOV
CLOV
ESTC
ESTC
Q4 25
0.4%
0.1%
Q3 25
0.1%
0.2%
Q2 25
0.1%
0.5%
Q1 25
0.0%
0.2%
Q4 24
0.5%
0.2%
Q3 24
0.1%
0.2%
Q2 24
0.1%
0.3%
Q1 24
0.1%
0.3%
Cash Conversion
CLOV
CLOV
ESTC
ESTC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24
0.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

ESTC
ESTC

Self Managed Subscription$192.0M45%
Saa S Self Managed Annual$156.9M37%
Saa S Self Managed Monthly$48.8M12%
Professional Services$25.8M6%

Related Comparisons